These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

306 related items for PubMed ID: 21792478

  • 1.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 2. Aggravated renal inflammatory responses in TRPV1 gene knockout mice subjected to DOCA-salt hypertension.
    Wang Y, Wang DH.
    Am J Physiol Renal Physiol; 2009 Dec; 297(6):F1550-9. PubMed ID: 19794112
    [Abstract] [Full Text] [Related]

  • 3. Role of the monocyte chemoattractant protein-1/C-C chemokine receptor 2 signaling pathway in transient receptor potential vanilloid type 1 ablation-induced renal injury in salt-sensitive hypertension.
    Wang Y, Zhu M, Xu H, Cui L, Liu W, Wang X, Shen S, Wang DH.
    Exp Biol Med (Maywood); 2015 Sep; 240(9):1223-34. PubMed ID: 25585624
    [Abstract] [Full Text] [Related]

  • 4. Deletion of transient receptor potential vanilloid type 1 receptors exaggerates renal damage in deoxycorticosterone acetate-salt hypertension.
    Wang Y, Babánková D, Huang J, Swain GM, Wang DH.
    Hypertension; 2008 Aug; 52(2):264-70. PubMed ID: 18606907
    [Abstract] [Full Text] [Related]

  • 5. [Role of transient receptor potential vanilloid type 1 and C-C chemokine receptor 2 in renal injury induced by salt-sensitive hype].
    Zhu FY, Liu WH, Wang XX, Cui L, Shen S, Zhu MJ, Wang YP.
    Zhongguo Yi Xue Ke Xue Yuan Xue Bao; 2014 Oct; 36(5):488-95. PubMed ID: 25360645
    [Abstract] [Full Text] [Related]

  • 6. Activation of TRPV4 by dietary apigenin antagonizes renal fibrosis in deoxycorticosterone acetate (DOCA)-salt-induced hypertension.
    Wei X, Gao P, Pu Y, Li Q, Yang T, Zhang H, Xiong S, Cui Y, Li L, Ma X, Liu D, Zhu Z.
    Clin Sci (Lond); 2017 Apr 01; 131(7):567-581. PubMed ID: 28143892
    [Abstract] [Full Text] [Related]

  • 7. Detrimental role of sphingosine kinase 1 in kidney damage in DOCA-salt hypertensive model: evidence from knockout mice.
    Lyu B, Wang W, Ji XY, Ritter JK, Li N.
    BMC Nephrol; 2020 May 11; 21(1):173. PubMed ID: 32393187
    [Abstract] [Full Text] [Related]

  • 8. Enhanced postmyocardial infarction fibrosis via stimulation of the transforming growth factor-beta-Smad2 signaling pathway: role of transient receptor potential vanilloid type 1 channels.
    Huang W, Rubinstein J, Prieto AR, Wang DH.
    J Hypertens; 2010 Feb 11; 28(2):367-76. PubMed ID: 19887954
    [Abstract] [Full Text] [Related]

  • 9. Angiotensin II induces connective tissue growth factor and collagen I expression via transforming growth factor-beta-dependent and -independent Smad pathways: the role of Smad3.
    Yang F, Chung AC, Huang XR, Lan HY.
    Hypertension; 2009 Oct 11; 54(4):877-84. PubMed ID: 19667256
    [Abstract] [Full Text] [Related]

  • 10. [Effects of Chinese herbal medicine Yiqi Huoxue Formula on TGF-β/smad signal transduction pathway and connective tissue growth factor in rats with renal interstitial fibrosis].
    Liu YM, Liu RH, Liu WJ, Liu L, Wu ZK, Chen YY.
    Zhong Xi Yi Jie He Xue Bao; 2010 Dec 11; 8(12):1165-73. PubMed ID: 21144460
    [Abstract] [Full Text] [Related]

  • 11. Heme arginate therapy enhanced adiponectin and atrial natriuretic peptide, but abated endothelin-1 with attenuation of kidney histopathological lesions in mineralocorticoid-induced hypertension.
    Ndisang JF, Jadhav A.
    J Pharmacol Exp Ther; 2010 Jul 11; 334(1):87-98. PubMed ID: 20392817
    [Abstract] [Full Text] [Related]

  • 12. Renal protective effects of N-acetyl-Ser-Asp-Lys-Pro in deoxycorticosterone acetate-salt hypertensive mice.
    Rhaleb NE, Pokharel S, Sharma U, Carretero OA.
    J Hypertens; 2011 Feb 11; 29(2):330-8. PubMed ID: 21052020
    [Abstract] [Full Text] [Related]

  • 13.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 14.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 15.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 16.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 17.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 18.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 19.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 20.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 16.